“A recent review of phase III randomized trials of COVID-19 mRNA vaccines showed an increased risk of hospitalization for the vaccinated compared to controls.
Data from the Swedish Medical Products Agency (LV) confirms that COVID-19 vaccines have resulted in a distinct increase in reported side effects, including suspected serious side effects (SSSEs) and deaths. Despite this, the consistent message from the Swedish Public Health Agency (FoHM) is that benefit outweighs risk. Does the evidence support this assertion?
With the aim of determining the relative risk of experiencing a SSSE including death, versus becoming hospitalized or dying with COVID-19, we analyzed publicly available data from LV, FoHM …
Assuming that 5% of all SSSEs are reported in Sweden, our analysis shows that COVID-19 vaccination is likely to benefit one single group only – men aged over 90 years …”